Similarly, the involvement of NF-kB in TRAIL/NF-κB/CX3CL1-mediated oncoimmuno crosstalk resulting in TNFα-related apoptosis-inducing ligand (TRAIL) resistance signifies the role of NF-kB in pancreatic cancer [32]. This evidence concerns the gene NFKB1 and familial pancreatic carcinoma.